# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-032118
Filing Date
2025-04-15
Accepted
2025-04-15 16:23:46
Documents
122
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0232540-10k_abvcbio.htm iXBRL | 10-K | 2241096
2 | LAND TRANSFER PLAN DATED MARCH 31, 2025 | ea023254001ex10-56_abvcbio.htm | EX-10.56 | 5945
3 | NOMINEE HOLDING AGREEMENT DATED APRIL 1, 2024 | ea023254001ex10-57_abvcbio.htm | EX-10.57 | 1368
4 | LAND LEASE AGREEMENT DATED APRIL 1, 2024 | ea023254001ex10-58_abvcbio.htm | EX-10.58 | 1400
5 | ADDENDUM TO DEFINITIVE LICENSING AGREEMENT BETWEEN ABVC AND AIBTL DATED MARCH 11 | ea023254001ex10-59_abvcbio.htm | EX-10.59 | 32887
6 | ADDENDUM TO DEFINITIVE LICENSING AGREEMENT BETWEEN BIOLITE AND AIBTL DATED MARCH | ea023254001ex10-60_abvcbio.htm | EX-10.60 | 34599
7 | YUNZHIYI LAND HOLDING AGREEMENT DATED OCTOBER 28, 2024 | ea023254001ex10-61_abvcbio.htm | EX-10.61 | 2443
8 | LIST OF SUBSIDIARIES | ea023254001ex21-1_abvcbio.htm | EX-21.1 | 5746
9 | CERTIFICATION | ea023254001ex31-1_abvcbio.htm | EX-31.1 | 12280
10 | CERTIFICATION | ea023254001ex31-2_abvcbio.htm | EX-31.2 | 12320
11 | CERTIFICATION | ea023254001ex32-1_abvcbio.htm | EX-32.1 | 4881
12 | CERTIFICATION | ea023254001ex32-2_abvcbio.htm | EX-32.2 | 4958
13 | GRAPHIC | image_001.jpg | GRAPHIC | 35654
14 | GRAPHIC | image_002.jpg | GRAPHIC | 21048
15 | GRAPHIC | ex10-56_001.jpg | GRAPHIC | 10407
16 | GRAPHIC | ex10-56_002.jpg | GRAPHIC | 6599
17 | GRAPHIC | ex10-57_001.jpg | GRAPHIC | 650029
18 | GRAPHIC | ex10-57_002.jpg | GRAPHIC | 575218
19 | GRAPHIC | ex10-58_001.jpg | GRAPHIC | 692836
20 | GRAPHIC | ex10-58_002.jpg | GRAPHIC | 238507
26 | GRAPHIC | ex10-61_001.jpg | GRAPHIC | 219603
27 | GRAPHIC | ex10-61_002.jpg | GRAPHIC | 213339
28 | GRAPHIC | ex10-61_003.jpg | GRAPHIC | 209089
29 | GRAPHIC | ex10-61_004.jpg | GRAPHIC | 54644
| Complete submission text file | 0001213900-25-032118.txt |  | 15780158

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
21 | XBRL SCHEMA FILE | abvc-20241231.xsd | EX-101.SCH | 100741
22 | XBRL CALCULATION FILE | abvc-20241231_cal.xml | EX-101.CAL | 61665
23 | XBRL DEFINITION FILE | abvc-20241231_def.xml | EX-101.DEF | 509101
24 | XBRL LABEL FILE | abvc-20241231_lab.xml | EX-101.LAB | 870299
25 | XBRL PRESENTATION FILE | abvc-20241231_pre.xml | EX-101.PRE | 540909
125 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0232540-10k_abvcbio_htm.xml | XML | 1332626

Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40700 | Film No.: 25839779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)